Clinical Trial Update: A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Vimseltinib in adults with active chronic graft-versus-host disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Vimseltinib (Vimseltinib)

Snippet

Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: Chronic Graft-Versus-Host Disease (cGVHD) | Phase 2 | Status: RECRUITING